Bad Pharma: How drug companies mislead doctors and harm patients
Ben Goldacre (auteur de Bad Science)
HarperCollins
(disponible à la BAnQ)
….
The Economist described the book as “slightly technical, eminently readable, consistently shocking, occasionally hectoring and unapologetically polemical. … This is a book that deserves to be widely read, because anyone who does read it cannot help feeling both uncomfortable and angry.”[34]
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products.[1] The book was first published in September 2012 in the UK by the Fourth Estateimprint of HarperCollins. It was published in the United States in February 2013 by Faber and Faber.
Goldacre argues in the book that “the whole edifice of medicine is broken,” because the evidence on which it is based is systematically distorted by the pharmaceutical industry.[2] He writes that the industry finances most of the clinical trials into its products, that it routinely withholds negative data, that trials are often conducted on small groups of unrepresentative subjects, that it funds much of doctors’ continuing education, and that apparently independent academic papers may be planned and evenghostwritten by pharmaceutical companies or their contractors, without disclosure.[3] Goldacre calls the situation a “murderous disaster,” and makes a number of suggestions for action by patients’ groups, physicians, academics and the industry itself.[4]
Source: Wikipedia
…
Luisa Dillner praises a calmly outraged investigation into the drugs industry.